GeneHealth - Your precision medicine

Arthritis

Disease Details

Family Health Simplified

Buy Membership

Health Insights (Sample Report)

This is sample data. Based on the provided genetic variants and associated parameters, your risk profile suggests a predisposition to the condition.

Variant ID	Allele Associated	Your Genotype	Risk Score
rs12193446	A	A/A	Low
rs524952	A	T/A	Low
rs7744813	A	A/A	Low
rs17648524	C	G/C	Low

Associated Proteins	Pathway
NP_001706.2 , NP_002113.2	REACT:R-HSA-2168880 , KEGG:hsa05143 , REACT:R-HSA-2173782

Clinical Trials

To interpret these results, it is advisable to consider consulting a healthcare professional specializing in genetic counseling or a medical geneticist.

Description: Arthritis is an inflammatory condition affecting the joints, causing pain, stiffness, and swelling.
Type: Arthritis is not a single disease but a term that refers to a group of more than 100 different types of conditions affecting the joints. The two most common types are:

1. **Osteoarthritis (OA)**: Primarily caused by wear and tear on the joints.
2. **Rheumatoid Arthritis (RA)**: An autoimmune condition where the immune system attacks the joints.

**Type of Genetic Transmission:**

- **Osteoarthritis (OA)**: Genetic factors can predispose individuals to developing OA, but it is not directly inherited in a simple Mendelian fashion. Instead, it usually results from a combination of genetic susceptibility and environmental factors.

- **Rheumatoid Arthritis (RA)**: RA has a stronger genetic component compared to OA. It is often associated with specific genetic markers like the HLA-DRB1 gene. Although having these markers increases the risk, the transmission is complex and involves multiple genes along with environmental triggers.

Both types involve multifactorial inheritance, meaning they result from the interaction of multiple genes and environmental factors.
Signs And Symptoms: Pain, which can vary in severity, is a common symptom in virtually all types of arthritis. Other symptoms include swelling, joint stiffness, redness, and aching around the joint(s). Arthritic disorders like lupus and rheumatoid arthritis can affect other organs in the body, leading to a variety of symptoms. Symptoms may include:
Inability to use the hand or walk
Stiffness in one or more joints
Rash or itch
Malaise and fatigue
Weight loss
Poor sleep
Muscle aches and pains
Tenderness
Difficulty moving the jointIt is common in advanced arthritis for significant secondary changes to occur. For example, arthritic symptoms might make it difficult for a person to move around and/or exercise, which can lead to secondary effects, such as:

Muscle weakness
Loss of flexibility
Decreased aerobic fitnessThese changes, in addition to the primary symptoms, can have a huge impact on quality of life.
Prognosis: The prognosis of arthritis varies widely depending on the type, severity, and how early it is diagnosed and treated. Many forms, such as osteoarthritis, are chronic and progressive but can be managed with lifestyle changes, medications, and sometimes surgery to improve quality of life. Rheumatoid arthritis, an autoimmune condition, can lead to joint damage and disability if not adequately controlled, but modern treatments have significantly improved outcomes. Early diagnosis and appropriate management are key to better prognoses in both cases. Nanotechnology is an emerging field promising more targeted treatment options, potentially improving the outlook for arthritis patients in the future.
Onset: Arthritis can onset at any age, but is more commonly seen in older adults. Certain types, like juvenile idiopathic arthritis, can occur in children. Factors such as genetics, lifestyle, and gender may influence the onset and progression of the disease.
Prevalence: Arthritis is a common condition that affects millions of people worldwide. In the United States, it is estimated that about 24% of adults, or approximately 58.5 million people, have been diagnosed with some form of arthritis. The prevalence increases with age, and it is more common in women than in men. Osteoarthritis and rheumatoid arthritis are the two most common types. The prevalence varies globally, with higher rates generally seen in more developed countries due to longer life expectancy and changes in lifestyle factors.
Epidemiology: Arthritis is predominantly a disease of the elderly, but children can also be affected by the disease. Arthritis is more common in women than men at all ages and affects all races, ethnic groups and cultures. In the United States a CDC survey based on data from 2013 to 2015 showed 54.4 million (22.7%) adults had self-reported doctor-diagnosed arthritis, and 23.7 million (43.5% of those with arthritis) had arthritis-attributable activity limitation (AAAL). With an aging population, this number is expected to increase. Adults with co-morbid conditions, such as heart disease, diabetes, and obesity, were seen to have a higher than average prevalence of doctor-diagnosed arthritis (49.3%, 47.1%, and 30.6% respectively).Disability due to musculoskeletal disorders increased by 45% from 1990 to 2010. Of these, osteoarthritis is the fastest increasing major health condition. Among the many reports on the increased prevalence of musculoskeletal conditions, data from Africa are lacking and underestimated. A systematic review assessed the prevalence of arthritis in Africa and included twenty population-based and seven hospital-based studies. The majority of studies, twelve, were from South Africa. Nine studies were well-conducted, eleven studies were of moderate quality, and seven studies were conducted poorly. The results of the systematic review were as follows:
Rheumatoid arthritis: 0.1% in Algeria (urban setting); 0.6% in Democratic Republic of Congo (urban setting); 2.5% and 0.07% in urban and rural settings in South Africa respectively; 0.3% in Egypt (rural setting), 0.4% in Lesotho (rural setting)
Osteoarthritis: 55.1% in South Africa (urban setting); ranged from 29.5 to 82.7% in South Africans aged 65 years and older
Knee osteoarthritis has the highest prevalence from all types of osteoarthritis, with 33.1% in rural South Africa
Ankylosing spondylitis: 0.1% in South Africa (rural setting)
Psoriatic arthritis: 4.4% in South Africa (urban setting)
Gout: 0.7% in South Africa (urban setting)
Juvenile idiopathic arthritis: 0.3% in Egypt (urban setting)
Intractability: Arthritis is generally considered a chronic condition that may not be curable but can be managed effectively. Its intractability depends on the type and severity of the arthritis. While some forms, like osteoarthritis, can be managed with lifestyle changes, medications, and sometimes surgery, others like rheumatoid arthritis may require more aggressive treatment but can still be controlled to improve quality of life. Therefore, while it may not be entirely curable, it is not entirely intractable with proper management.
Disease Severity: Arthritis severity can vary widely from person to person, but it generally ranges from mild to severe. Severity is typically determined by the level of joint pain, inflammation, and loss of function experienced. In mild cases, people may experience occasional discomfort and minimal joint damage, while severe cases can involve chronic pain, significant joint damage, and major limitations in daily activities. Regular monitoring and appropriate management are critical to preventing progression and maintaining quality of life.
Healthcare Professionals: Disease Ontology ID - DOID:848
Pathophysiology: Arthritis is a broad term that encompasses various joint disorders. The pathophysiology varies depending on the specific type of arthritis:

1. **Osteoarthritis (OA)**: This is a degenerative joint disease characterized by the breakdown of cartilage, the tissue that cushions the ends of bones in joints. As cartilage deteriorates, bones begin to rub against each other, causing pain, swelling, and loss of movement. Risk factors include age, obesity, joint trauma, and genetic predisposition.

2. **Rheumatoid Arthritis (RA)**: RA is an autoimmune disorder in which the immune system mistakenly attacks the synovium—the lining of the membranes that surround the joints. This leads to chronic inflammation, thickening of the synovium, and eventually destruction of cartilage and bone within the joint. It often affects multiple joints symmetrically and can also cause systemic symptoms.

3. **Gout**: Gout occurs due to the accumulation of urate crystals within the joint, which results from high levels of uric acid in the blood. These crystals trigger an inflammatory response, leading to intense pain, redness, and swelling, typically starting in the big toe.

4. **Psoriatic Arthritis**: This type of arthritis occurs in some people with psoriasis (a skin condition). It is characterized by joint pain, stiffness, and swelling, which are caused by an autoimmune response targeting the joints and entheses (the areas where tendons or ligaments attach to bone).

In general, the pathophysiology of arthritis involves a combination of mechanical, inflammatory, and autoimmune mechanisms that ultimately lead to joint damage and functional impairment.
Carrier Status: Arthritis is not typically associated with a "carrier status" as it is not an infectious disease or one that follows a simple genetic carrier pattern like certain inherited genetic disorders. Arthritis is a broad term that encompasses various conditions affecting the joints, such as osteoarthritis, rheumatoid arthritis, and gout, among others. These conditions can result from a variety of factors, including genetic predisposition, age, joint injury, and autoimmune responses. If you are looking for information related to genetic predisposition to certain types of arthritis, specific genetic markers or family history could be relevant, particularly in rheumatoid arthritis.
Mechanism: Arthritis is a condition characterized by inflammation of the joints, which can lead to pain, swelling, stiffness, and reduced mobility. There are several types of arthritis, including osteoarthritis and rheumatoid arthritis, each with distinct mechanisms and molecular pathways.

**Mechanism of Arthritis:**
1. **Osteoarthritis (OA):**
- **Mechanical stress and wear-and-tear:** OA is primarily caused by the degeneration of cartilage due to mechanical stress and aging.
- **Joint cartilage breakdown:** Repetitive stress leads to the breakdown of cartilage, the smooth tissue that cushions bones in the joint.
- **Bone changes:** This can result in bone remodeling, including the formation of osteophytes (bone spurs).
- **Inflammation:** Although OA is less inflammatory than other forms of arthritis, the breakdown products of cartilage can still cause mild inflammation.

2. **Rheumatoid Arthritis (RA):**
- **Autoimmune disorder:** RA is an autoimmune condition where the immune system mistakenly attacks the synovium, the lining of the membranes that surround the joints.
- **Chronic inflammation:** This results in chronic inflammation and thickening of the synovium, which can eventually invade and destroy cartilage and bone within the joint.
- **Systemic involvement:** RA can also cause systemic symptoms affecting the entire body, including fatigue and organ involvement.

**Molecular Mechanisms of Arthritis:**
1. **Osteoarthritis (OA):**
- **Cytokines and enzymes:** Inflammatory cytokines such as IL-1β and TNF-α play a role in the degradation of matrix components in cartilage. Matrix metalloproteinases (MMPs) are enzymes that break down cartilage matrix proteins.
- **Biochemical pathways:** Oxidative stress and the imbalance between anabolic and catabolic processes in chondrocytes (cartilage cells) contribute to cartilage degradation.
- **Signaling pathways:** The Wnt/β-catenin and NF-κB signaling pathways are involved in the regulation of gene expression related to cartilage breakdown and inflammation.

2. **Rheumatoid Arthritis (RA):**
- **Autoantibodies:** The presence of autoantibodies like rheumatoid factor (RF) and anti-cyclic citrullinated peptide (anti-CCP) antibodies suggests an autoimmune process.
- **Cytokines:** Pro-inflammatory cytokines, such as TNF-α, IL-6, and IL-1, play pivotal roles in perpetuating inflammation and joint destruction.
- **T-cell and B-cell activation:** These immune cells are activated inappropriately and contribute to chronic inflammation through the production of cytokines and autoantibodies.
- **Synovial fibroblasts:** These cells become activated and contribute to the invasive and degradative processes within the joint through the production of MMPs and other proteolytic enzymes.

Understanding these mechanisms provides insights into potential therapeutic targets for managing and treating different forms of arthritis.
Treatment: There is no known cure for arthritis and rheumatic diseases. Treatment options vary depending on the type of arthritis and include physical therapy, exercise and diet, orthopedic bracing, and oral and topical medications. Joint replacement surgery may be required to repair damage, restore function, or relieve pain.
Compassionate Use Treatment: For arthritis, "compassionate use" refers to allowing patients with severe or life-threatening arthritis who have exhausted other treatment options to access investigational drugs or therapies that have not yet been approved by regulatory agencies. These are typically pursued when no comparable or satisfactory alternative treatments are available.

Off-label treatments for arthritis involve the use of drugs that are already FDA-approved for other conditions but are not specifically approved for arthritis. Examples of such off-label treatments may include:

1. **Low-dose Naltrexone (LDN)**: Originally approved for opioid addiction, it is sometimes used off-label for its anti-inflammatory and pain-relieving effects.
2. **Minocycline**: An antibiotic that has anti-inflammatory properties, sometimes used off-label for rheumatoid arthritis.
3. **Antidepressants like Amitriptyline**: Used off-label to manage chronic pain associated with arthritis.

Experimental treatments for arthritis are those that are still in the research phase and not yet widely available outside of clinical trials. These may include:

1. **Stem Cell Therapy**: Usage of mesenchymal stem cells to promote cartilage repair.
2. **Gene Therapy**: Research focused on altering genes to reduce inflammation or regenerate joint tissue.
3. **Biologics targeting new pathways**: New biologic drugs that target different pathways than the traditional TNF inhibitors and other existing biologics.

Patients interested in experimental treatments generally need to enroll in clinical trials to access these therapies.
Lifestyle Recommendations: ### Lifestyle Recommendations for Arthritis

1. **Exercise Regularly**:
- Engage in low-impact activities such as swimming, walking, and cycling to maintain joint function and alleviate stiffness.
- Incorporate strength training to support muscles around the joints.

2. **Maintain a Healthy Weight**:
- Aim for a balanced diet rich in fruits, vegetables, whole grains, and lean proteins to help reduce stress on weight-bearing joints.
- Avoid excessive calorie intake to prevent weight gain.

3. **Healthy Eating**:
- Include anti-inflammatory foods such as fish rich in omega-3 fatty acids, nuts, and seeds.
- Limit consumption of processed foods, sugary drinks, and high-fat foods.

4. **Stay Hydrated**:
- Drink plenty of water to maintain joint lubrication and overall health.

5. **Protect Your Joints**:
- Use joint protection techniques such as using ergonomic tools and taking breaks during repetitive activities.
- Wear supportive footwear to reduce joint strain.

6. **Get Adequate Rest**:
- Ensure you get enough sleep each night to allow your body to repair and reduce inflammation.
- Take short breaks throughout the day to avoid overexertion.

7. **Manage Stress**:
- Practice stress-reduction techniques such as yoga, meditation, or deep-breathing exercises.

8. **Stay Informed and Organized**:
- Keep track of your symptoms and any flare-ups to discuss with your healthcare provider.
- Stay informed about your condition and treatment options.

9. **Therapeutic Practices**:
- Consider physical therapy or occupational therapy to learn exercises and techniques tailored to your specific needs.
- Explore complementary therapies such as acupuncture or massage therapy.

10. **Avoid Smoking and Excessive Alcohol**:
- Smoking can exacerbate arthritis symptoms and overall health; seek help to quit if needed.
- Limit alcohol consumption as it can interact with medications and exacerbate inflammation.

These lifestyle changes can help manage arthritis symptoms and improve overall quality of life. Consulting with healthcare providers for personalized advice is recommended.
Medication: There are several types of medications that are used for the treatment of arthritis. Treatment typically begins with medications that have the fewest side effects with further medications being added if insufficiently effective.Depending on the type of arthritis, the medications that are given may be different. For example, the first-line treatment for osteoarthritis is acetaminophen (paracetamol) while for inflammatory arthritis it involves non-steroidal anti-inflammatory drugs (NSAIDs) like ibuprofen. Opioids and NSAIDs may be less well tolerated. However, topical NSAIDs may have better safety profiles than oral NSAIDs. For more severe cases of osteoarthritis, intra-articular corticosteroid injections may also be considered.The drugs to treat rheumatoid arthritis (RA) range from corticosteroids to monoclonal antibodies given intravenously. Due to the autoimmune nature of RA, treatments may include not only pain medications and anti-inflammatory drugs, but also another category of drugs called disease-modifying antirheumatic drugs (DMARDs). csDMARDs, TNF biologics and tsDMARDs are specific kinds of DMARDs that are recommended for treatment. Treatment with DMARDs is designed to slow down the progression of RA by initiating an adaptive immune response, in part by CD4+ T helper (Th) cells, specifically Th17 cells. Th17 cells are present in higher quantities at the site of bone destruction in joints and produce inflammatory cytokines associated with inflammation, such as interleukin-17 (IL-17).
Repurposable Drugs: Repurposable drugs for arthritis include:

1. **Methotrexate**: Originally used for cancer, now commonly used for rheumatoid arthritis due to its immunosuppressive properties.
2. **Sulfasalazine**: Initially used for inflammatory bowel disease, found effective for rheumatoid arthritis.
3. **Hydroxychloroquine**: Used for malaria, now also applied in managing lupus and rheumatoid arthritis.
4. **Minocycline**: An antibiotic, sometimes used for its anti-inflammatory effects in rheumatoid arthritis.
5. **Azathioprine**: An immunosuppressant used in organ transplantation, also found helpful for severe arthritis.

These drugs are not always the first line of treatment and may be considered based on specific cases and under medical supervision.
Metabolites: In arthritis, metabolites such as inflammatory cytokines (e.g., TNF-alpha, IL-1, and IL-6) and oxidative stress markers (e.g., reactive oxygen species) play a significant role in disease progression. Nanotechnology is being explored for arthritis treatment, with nanoparticles designed to deliver drugs directly to inflamed tissues to reduce side effects and improve therapeutic efficacy.
Nutraceuticals: Nutraceuticals for arthritis typically include dietary supplements such as glucosamine, chondroitin sulfate, omega-3 fatty acids, curcumin (from turmeric), and SAM-e (S-adenosylmethionine). These supplements aim to reduce inflammation, alleviate pain, and support joint health. However, their efficacy can vary, and it's important to consult with a healthcare provider before starting any new supplement regimen.
Peptides: Peptides are being explored for arthritis treatment due to their potential anti-inflammatory and chondroprotective properties. Certain peptides can target specific pathways involved in the inflammatory process and cartilage degradation, potentially offering relief and slowing disease progression.

Nanotechnology (nan) in arthritis treatment focuses on drug delivery systems, including nanoparticles that can deliver therapeutic agents directly to affected joints. This targeted delivery can enhance the efficacy of medications, reduce side effects, and improve patient outcomes by ensuring sustained and localized drug action.